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    Mice were irradiated lethally with gamma rays under high dose rate and were treated 
 with preserved homologous fetal liver. The homologous fetal liver was suspended in 15% 
 glycerol-Tyrode's solution or 10°o dimethyl-sulphoxide TC199 solution and preserved at 
—80°C as long as 360 days. The homologous fetal liver cells which were preserved as 
 long as 360 days could protect the lethally irradiated mice. 
                         INTRODUCTION
   Mice exposed to a lethal dose of X radiation survive acute irradiation damage 
when they are given a postirradiation inoculation of bone marrow or spleen 
cells". Inoculation of isologous bone marrow produces excellent recovery, while 
homologous bone marrow affords only a temporary recovery2' ; the mice succumb 
after 21 or 30 days. The transient nature of this recovery following inoculation 
of homologous marrow has been a subject of extensive investigations from which 
two main theories have emerged. Makinodan and his coworkers3'4'5' have evi-
dences which they feel support the host versus graft theory. However, Barnes 
and Loutit2' postulated an immune response of the graft versus host. There is 
an increasing body of evidences in support of this latter theory as an explantation 
of the cause of secondary disease and delayed death6-1a. If there exists a graft 
versus host reaction when adult bone marrow is used, fetal liver or spleen might 
not initiate such a reaction owing to its immunological nonreactivity or immatu-
rityli-14' 
                    MATERIALS AND METHODS 
   Mice. Dd/s and Na2 strain mice supplied exclusively from the Kyoto Univer-
sity Animals Center were used as recipients and donors of the homologous fetal 
liver, respectively. The irradiated mice, after fetal liver transplantation or in-
jection of only Tyrode's solution, were kept in wooden boxes measuring 15 x 21 x 
30cm. Eight to ten mice in a box were fed wheat supplemented with dried fish 
every other day and were given tap water ad libitum. 
* tiib 
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   Fetal liver cells suspensions. Isologous fetal livers (IFL) were obtained from 
the fetuses after the mating of Dd/s strain. The F1 hybrids fetal livers (SFL) 
were obtained from the fetuses after the  matings of female Dd/s strain and male 
Na2 strain mice. The homologous fetal livers (HFL) were obtained from the 
matings of Na2 strain mice. The donor tissue was obtained from fetuses of 15 to 
19 days gestation. The gestational age of the fetus was carefully determined from 
the external features of the mouse embryo by the method of Gruneberg15' . The 
livers of male and female donors of the same age were pooled. Suspensions of 
pooled fetal livers in Tyrode's solution or TC 199 solution were prepared by gentle 
aspiration through a syringe. The suspensions were filtered through the surgical 
gauzes and the suspensions were passed through a small needle (1/5 : usually 
used for the tuberculin test"') One fetal liver was suspended in 0.5cc of Tyr-
ode's solution or TC 199 solution. Glycerol was added so as to make the final 
concentration of 15% V/V16`20' and dimethylsulphoxide (DMSO) was added to 
make the final concentration of 10% V/V21°25'. There were about fourty million 
nucleated cells in one fetal liver. An ampoule containing 3.6cc of the fetal liver 
suspended in 15% glycerol-Tyrode's solution or 3.3cc of the fetal liver suspended 
in 10% DMSO-TC 199 solution was sealed with flame, The procedures were car-
ried out under aseptic conditions. Each recipients, except the mice in the control 
group, was given nucleated fetal liver cells via the tail vein within 4 to 6 hours 
after irradiation. The mice in the control group were lethally irradiated without 
any further treatment or were injected intravenously 0.5ml of Tyrode's solution. 
   Freezing and thawing. Slow freezing",20,27,281 means that the temperature 
was cooled at a rate of 1-2°C/min. from 0°C until -25°C and cooled to -80°C at 
a rate not exceeding 10°C/min. The method of slow freezing and fast thawing 
was described previously. 
   Irradiation. A Co60 gamma-irradiation facility which belongs to the Institute 
for Chemical Research of Kyoto University was used in the experiments. This 
facility was described in detail29,3°'. All recipients were exposed to a single 
LD99/14 days, LD100/21 days dose of total body irradiation of 900r which was ob-
tained by the irradiation time of 27 sec. in October, 1962, and of 32 sec. in October, 
1964. 
   Cell viability. As a screening test, the eosin staining method31' was used as 
described previously. 
                           RESULTS 
   1. Some Observations on the Basic Method of Fetal Liver Transplantation 
   Exp. 1. The experiment was carried out to protect the lethally irradiated 
mice with the fresh fetal liver which was suspended in Tyrode's solution. Table 
1 shows the survival rates of irradiated mice treated with the isologous fetal liver 
(IFL), the F1 hybrids fetal liver (SFL) and the homologous fetal liver (HFL). 
The survival rates in IFL treatment was as follows : 100% at 14 days, 100% at 
30 days, 75% at 60 days and 75% at 120 days after irradiation. The survival rates 
in SFL treatment were as follows : 91% at 14 days, 78% at 21 days, 47% at 30 
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               Table 1. Survival rate of gamma-irradiated mice treated with HFL. 
                   Number of survival% 
           No.of(at days)!Survival       Cell numberNumber of irradiated (at days) 
                 experiment 14 21 30  60 90 12021 30 60 90 120 
      Control  44  2/162  0/162  —  —  —  0— — —  — 
          IFL 2  19/19  18/18  16/16  12/16  12/16  12/16  100  100 75  75  75 
         SFL4 22/24 18/23 11/23 7/23 4/23 3/23 78 47 30 17 13 
5 x 106 HFL 2 17/19 16/18 14/16 10/16 9/16 8/16 88 87 62 52 50 
10 x 106 HFL 2 18/22 13/22 9/21 4/20 3/20 2/20 59 42 20 15 10 
20 X106 HFL 5 27/33 18/33 11/33 5/32 4/32 4/32 54 34 15 12 12 
        Control means the group of gamma-irradiated mice treated with only Tyrode's solution 
           or nothing. 
        IFL means the group of gamma-irradiated mice treated with IFL when the number of 
          nucleated cells injected was 20 million. 
        SFL means the F1-hybrids fetal liver transplantation when the number of nucleated 
          cells injected was 20 million. 
5x106 HFL means the HFL transplantation when the number of nucleated cells injec-
          ted was 5 million. 
10x106 HFL means the HFL transplantation when the number of nucleated cells injce-
          ted was 10 million. 
        20 x 106 HFL means the HFL transplantation when the number of nucleated cells injec-
          ted was 20 million. 
    days, 30% at 60 days, 17% at 90 days and 13% at 120 days. The survival rates 
    in HFL treatment in which the number of nucleated cells injected was 5 million 
    were as follows : 89% at 14 days, 88% at 21 days, 87% at 30 days, 62% at 60 days 
    and 50% at 120 days. The survival rates in HFL treatment in which the number 
    of nucleated cells injected was 10 million were as follows : 89% at 14 days, 59% 
    at 21 days, 20% at 60 days and 10% at 120 days. The survival rates in HFL 
    treatment in which the number of nucleated cells injected was 20 million were 
    as follows : 81% at 14 days, 54% at 21 days, 34% at 30 days, 15% at 60 days and 
    12% at 120 days. The survival rates in IFL transplantation are excellent as in 
    isologous bone marrow transplantation. Generally speaking, the HFL cells or 
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        Fig. 1. Body weight changes in the mice irradiated lethally and treated with fetal 
liver. The number of nucleated cells injected was 20 million. They were suspended 
          in Tyrode's solution. The left figure shows the changes in the mice treated with 
          IFL. The right figure shows the changes in the mice treated with SFL.
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             Fig. 2. Body weight changes in the mice irradiated lethally and treated with FL. 
                  The cells were suspended in Tyrode's solution. The left figure shows the changes 
               in HFL treatment in which the number of nucleated cells injected was 5 million. 
               The right figure shows the changes in HFL treatment in which the number of 
               nucleated cells injected was 10 million. 
         SFL cells protected the lethally irradiated mice from the early death better than 
          the homologous bone marrow did. 
            Body weight chahges. The changes of body weight in IFL and SFL trans-
         plantations are shown in Fig. 1. The changes in HFL transplantation are shown 
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             Fig. 3. Body weight changes in the mice irradiated lethally and treated with HFL. 
The number of nucleated cells injected was 20 million. They were suspended in 
                 Tyrode's solution. 
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               Fig. 4. Leucocyte count in gamma-irradiated mice treated with fetal liver cells. 
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in Fig. 2. The changes of body weight in  20  x 106 HFL cells transplantation are 
shown in Fig. 3. The changes in IFL transplantation were similar to those in 
the isologous bone marrow transplantation. The lowest level of body weight 
after irradiation occurred at 7 days and then the body weight quickly increased 
to the preirradiation level at 18 days after irradiation. In other kinds of trans-
plantation three types in the changes of body weight which were described in 
the homologous bone marrow transplantation were seen, namely, a-, b- and c-
typea20a> . 
   Hematological findings. Leucocyte count. The changes of leucocyte count in 
the experiments are shown in Fig. 4. The leucocyte count in the treated mice 
showed a rapid decrease to 500 to 1000 at 4 to 7 days. And then the count began 
to increase quickly or gradually and recovered to the normal level at 12 to 28 
days. The HFL treatment in which the number of nucleated cells injected was 
5 x106 or 10 X106 showed a retarded recovery. 
   Erythrocyte count. The changes of erythrocyte count in the treated ones are 
shown in Fig. 5. The lowest of the erythrocyte count occurred at 4 to 14 days, 
then the count increased gradually or quickly and recovered to the level of preir-
radiation at 10 to 30 days. However, the HFL treatments, in which the number 
of nucleated cells injected was 5 X 106 or 10 X106, showed a retarded recovery. 
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       Fig. 5. Erythrocyte count in the gamma-irradiated mice treated with FL. 
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       Fig. 6. Reticulocyte count in the gamma-irradiated mice treated with FL. 
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are shown in Fig. 6. The reticulocyte count in the treated mice decreased to 
zero by 2 to 6 days. It increased quickly or gradually starting at 4 days and 
showed one crisis of reticulocyte count. The peaks of the crisis appeared at 7 to 
21 days. The count recovered to the preirradiation level at 18 to 45 days. Gene-
rally speaking, the  times of appearance of the peaks and the recovery was 
retadred in the HFL treatments in which the number of nucleated cells injected 
was 5 X 106 or 10 X 106. 
   Platelet count. The changes of platelet count are shown in Fig. 7. The 
count decreased to the level of 250 to 200 x106 at about 3 to 7 days and then in-
creased rapidly or gradually to the level of preirradiation at 13 to 30 days. 
However, the HFL transplantation in which the number of nucleated cells in-
jected was 5 million showed a slower recovery. 
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         Fig. 7. Platelet count in the gamma-irradiated mice treated with FL. 
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    Fig. 8. Hemoglobin content in the mice irradiated lethally and treated with FL. 
   Hemoglobin content. Hemeglobin content was examined by the Sahli method. 
The changes of hemoglobin content are shown in Fig. 8. The hemoglobin content 
in the treated mice decreased to the level of 83-110% at 4 to 17 days after irradia-
tion and then increased to the level of preirradiation at 7 to 35 days. The HFL 
transplantations in which the number of nucleated cells injected was 5 million 
and 10 million showed a retarded recovery. 
   Histological findings. The times of appearance of early regeneration and 
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   Table 2. The times of appearance of early regeneration and complete recovery in the 
    hematopoietic tissues in gamma-irradiated mice treated with fetal liver. 
 Bone  marrowSpleenThymusLymphnode  Cell numberredpulp white pulpyp 
eg. cp, eg. cp. eg. cp. eg. cp. eg. cp. 
IFL 4 14 6 21 14 21 8 14 20 30 
SFL 5 14 6 21 21 30 9 28 21 45 
  5 x 106 HFL 4 14 6 25 — 50 — 50 — 50 
10 X 106 HFL 4 17 7 28 — 5050 — 50 
  20 x 106 HFL 4 14 7 21 — 70-90 10 70-90 — 70-90 
   eg. means early regeneration in the tissues in the mice which were lethally irradia-
    ted and treated with fetal liver. 
   cp. means complete recovery in the tissues in the mice which were lethally irradia-
    ted and treated with fetal liver. 
complete recovery are shown in Table 2. 
   Bone marrow. The sternal and femoral bone marrow were examined. Early 
regeneration was initiated on the 4th to 6th day. Complete recovery was dis-
cernible on the 14th to 18th day. However, the complete recovery in the HFL 
transplantations in which the number of nucleated cells injected was 5 million 
and 10 million was slightly retarded by 3 to 7 days. 
   Spleen. The red pulp. Early regeneration in the red pulp was discernible on 
the 6th to 8th day and complete recovery was seen on the 21st to 25th day. 
The recovery to a normal cellularity was a little slower in the HFL transplanta-
tion in which the number of nucleated cells injected was 5 million or 10 million. 
   The white pulp. The early regeneration in the white pulp in IFL transplanta-
tion was discernible on the 14th day and the complete recovery was seen on the 
28th day. In the transplantation other than IFL, complete recovery of the white 
pulp was retarded. 
   Thymus. Early regeneration in the thymus in IFL treatment was initiated on 
the 8th day and complete recovery was discernible on the 14th day. The early 
regeneration in the thymus after SFL treatment was initiated on the 28th day 
and a normal cellularity was discernible on the 35th day. Complete recovery in 
the thymus after HFL treatment was very much retarded. 
   The lymphatic tissues. Early regeneration in the lymphatic tissues was seen 
on the 14th day and complete recovery was seen on the 28th day IFL treat-
ment. In other treatments, the times of appearance of early regeneration and 
complete recovery were very much retarded. 
   2. Some Observations on Long Term Preservation of Mouse Fetal Liver 
   This experiment was made to protect the lethally irradiated mice with the 
homologous fetal liver cells which were suspended in 15% glycerol-Tyrode's solu-
tion or 10% DMSO-TC 199 solution and were stored at — 80°C by slow freezing 
and used afte fast thawing. 
   I. Fetal liver suspended in 15% glycerol-Tyrode's solution. 
   Survival rates. The survival rates in the experiment are shown in Fig. 9 
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   Fig. 9. Changes of percent survival in the mice irradiated lethally and treated with 
     preserved HFL. The number of nucleated cells injected was 20 million. They were 
     suspended in 15% glycerol-Tyrode's solution and preserved for 30 to 360 days at 
—80°C. 
     Table 3. Survival rates of gamma-irradiated mice treated with preserved HFL. 
                           Percent Number of survival  (at days)% Survival 
   Preservation No. of staining Number of irradiated(at days) 
    period experiment with eosin  ----------------- (%) 
14 21 30 60 90 120 21 30 60 90 120 
Control 44 — 2/162 0/162 — — — — 0 — — — — 
     Fresh5 23 27/33 18/33 11/32 5/32 4/32 4/32 54 34 15 12 12 
     30 days 2 28 4/14 3/13 3/13 3/13 3/13 3/13 23 23 23 23 23 
     60 days 2 26 9/11 5/11 4/11 0/11 0/11 0/11 45 35 0 0 0 
     90 days 2 28 9/11 7/11 6/11 4/11 4/11 4/11 63 54 36 36 36 
    120 days 2 26 11/14 4/14 2/14 1/14 1/14 2/14 28 14 7 7 7 
    150 days 2 35 9/15 7/15 4/15 1/15 0/15 0/15 46 26 6 0 0 
    180 days 2 45 11/15 10/15 6/15 0/15 0/15 0/15 66 40 0 0 0 
    270 days 2 53 7/16 4/15 4/15 3/14 3/14 3/14 26 26 21 21 21 
    360 days 3 91 16/20 9/20 7/18 3/17 2/16 2/16 45 38 17 12 12 
   The number of nucleated cells injected was 20 million. They were suspended in 15% 
     glycerol-Tyrode's solution and preserved for 30 to 360 days at —80°C. 
and Table 3. The number of nucleated cells injected was 20 million. The survival 
rates in the 30-day preserved HFL treatment were as follows : 28% at 14 days, 
23% at 21 days, 23% at 120 days. The survival rates in a 360-day preserved HFL 
transplantation were as follows : 80% at 14 days, 45% at 21 days, 38% at 30 days, 
17% at 60 days, 12% at 90 days, 12% at 120 days. It was found that the 360-day 
preserved HFL could protect the lethally irradiated mice as well as the fresh 
HFL did. 
   Body weight changes. The changes of body weight in the treatment are 
show in Fig. 10. The three types described in the homologous bone marrow 
transplantation were observed. B-type was not seen in 60, 150 and 180 days 
preserved HFL transplantations. 
Hematological findings. Leucocyte count. The changes of leucocyte count in 
the experiment are shown in Fig. 11. The count in the treated ones showed a 
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 rapid  decrease at 4 to 9 days and then the count began to increase quickly or 
gradually and the time of recovery to the normal level was at 12 to 28 days. 
However, the time in the 360-day preserved HFL transplantation was later than 
those in the transplantation with HFL preserved for periods shorter than 360 days. 
   Erythrocyte count. The changes of erythrocyte count in the treated ones 
are shown in Fig. 12. The lowest level of the count occurred at 4 to 14 days and 
the count increased gradually or quickly and recovered to the level of preirradia-
tion at 9 to 21 days. 
   Reticulocyte count. The changes of reticulocyte count in the treated ones are 
shown in Fig. 13. The count in the treated ones decreased to zero by 2 to 5 days. 
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    Fig. 10. Body weight changes in the mice irradiated lethally and treated with 
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  Fig. 11. Leucocyte count in the gamma-irradiated mice treated with preserved HFL. 
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  Fig. 12. Erythrocyte count in the gamma-irradiated mice treated with preserved HFL. 
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   Fig. 13. Reticulocyte count in gamma-irradiated mice treated with preserved HFL. 
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    Fig. 14. Platelet count in the gamma-irradiated mice treated with preserved HFL. • 
It increased quickly or gradually at 6 days and showed one crisis. The peaks of 
the crisis were at 10 to 18 days. 
   Platelet count. The changes of platelet count are shown in Fig. 14. The 
count decreased to the level of 270 to 100X 108 at about 2 to 9 days. They in-
creased rapidly or gradually and reached the level of preirradiation at 11 to 
28 days. 
   Hemoglobin content. The changes of hemoglobin content are shown in Fig. 15. 
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   Fig. 16. The percentage of neutrophils in the gamma-irradiated mice treated with 
     preserved HFL. 
  Table 4. The time of appearence of early regeneration and complete recovery in the 
   hematopoietic tissues in gamma-irradiated mice treated with HFL. 
Spleen 
   Preservation Bone marrow red pulp white pulp Thymus Lymphnode 
period eg. cp. eg. cp. eg. cp. eg. cp. eg. cp. 
    Fresh 4 14 7 21 — 70-90 10 70-90 — 70-90 
   30 days 6 15 8 21 — 100 — 100 — 100 
   270 days , 6 14 8 15 50 90 14 50 — 90 
  360 days 5 18 6 20 — 120 14 85 — 90 
  The number of nucleated cells injected was 20 million. They were suspended in 15% 
    glycerol-Tyrode's solution and preserved for 30 to 360 days at —80°C. 
  eg. means early regeneration in the tissues in the mice which were lethally irradia-
    ted and treated with HFL. 
  cp. means complete recovery in the tissues in the mice which were lethally irradia-
    ted and treated with HBM. 
  The numbers in the Table show the days after irradiation. 
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        The hemoglobin content in the treated ones decreased to the level of 70 to 99% 
        Sahli at 4 to 15 days and then increased to the level of preirradiation at 14 to 
         28 days. 
            Percentage of neutrophils. The changes of percentage of neutrophils in the 
         peripheral blood are shown in Fig. 16. The percentage of neutrophils is neutro-
         philic leucocytes/neutrophilic leucocytes+mononuclear cells. Peaks of the percent-
        age appeared between 11 and 21 days and they recovered to the level of preir-
         radiation between 21 and 35 days after irradiation. 
            Histological findings. The times of appearance of early regeneration and 
         complete recovery are shown in Table 4. The times of appearance of early 
         regeneration and complete recovery of the bone marrow and the red pulp of the 
         spleen were almost the same as those in the fresh IFL transplantation. However, 
         complete recovery in the lymphatic tissues came later than that in the IFL trans-
          plantation. 
           II. This experiment was made to protect lethally irradiated mice with HFL 
        which was suspended in 10% DMSO-TC 199 solution and preserved for 30 to 360 
         days at —80°C. 
            Survival rates. The survival rates in the experiment are shown in Fig. 17 
        and Table 5. The number of nucleated cells injected was 20 million. The sur-
         vival rates in the 30-day preserved HFL transplantation were as follows : 68% 
        at 14 days, 42% at 21 days, 40% at 30 days, 15% at 60 days, 15% at 120 days. 
         The survival rates in the 270 days preserved HFL transplantation were as 
        follow : 87% at 14 days, 56% at 21 days, 50% at 30 days, 43% at 60 days, 37% at 
        90 days, 37% at 120 days. The survival rates in the 360-day preserved HFL 
        transplantation were as follows : 80% at 14 days, 20% at 21 days, 12% at 30 days, 
        8% at 60 days, 8% at 120 days. 
            Body weight changes. The body weight changes in the treatments are shown 
                Table 5. Survival rates of gamma-irradiated mice treated with preserved HFL. 
                                     Percent Number of survival  (at days)°,Survival
             Preservation No. of staining Number of irradiated(at days) 
            periodexperiment with eosin ----------------- (%) 
14 21 30 60 90 120 21 30 60 90 120 
Control44 — 2/162 0/162 — — — — 0 — — — — 
             Fresh5 23 27/33 18/33 11/32 5/32 4/32 4/32 54 34 15 12 12 
             30 days3 30 15/22 9/21 8/20 3/20 3/20.3/20 42 40 15 15 15 
             60 days2 55 7/15 4/15 1/15 1/15 1/15 1/15 26 6 6 6 6 
             90 days2 29 9/11 4/11 1/11 1/11 1/11 1/11 36 9 9 9 9 
            120 days2 47 4/16 2/16 0/16 0/16 0/16 0/16 12 0 0 0 0 
            150 days2 22 6/18 1/18 1/18 0/18 0/18 0/18 15 15 0 0 0 
180 days2 43 7/17 2/17 2/17 2/17 1/17 1/17 11 11 11 5 5 
270 days2 58 14/16 9/16 8/16 7/16 6/16 5/16 56 50 43 37 27 
            360 days3 74 12/25 5/24 3/24 2/24 2/24 2/24 20 12 8 8 8 
             The number of nucleated cells injected was 20 million. They were suspended in 10% 
               DMSO-TC199 solution and preserved for 30 to 360 days at —80°C.
(48)
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  Fig. 17. Changes of percent survival in the mice irradiated lethally and treated with 
    preserved HFL. The number of nucleated cells injected was 20 million. They were 
    suspended in 10% DMSO-TC199 solution and preserved for 30 to 360 days at —80°C. 
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       Fig. 18. Body weight changes in the mice irradiated lethally and treated , 
         with preserved HFL. 
in Fig. 18. The three types described as previously were seen. B-type was not 
seen in the 120 and 150 days preserved HFL transplantation. 
   Hematological findings. Leucocyte count. The changes of leucocyte count in 
the experiment are shown in Fig. 19. The count in the treated ones showed a 
rapid decrease at 2 to 8 days and then the count began to increase quickly or 
gradually and the time of recovery to normal level was at 12 to 21 days. 
   Percentage of neutrophils. The changes of percentage of neutrophils in the 
peripheral blood are shown in Fig. 20. Peaks of the neutrophils count appeared 
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   Fig. 19. Leucocyte count in the gamma-irradiated mice treated with preserved HFL. 
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      Fig. 20. The percentage of neutrophils in the gamma-irradiated mice treated 
       with preserved HFL. 
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  Fig. 21. Erythrocyte count in the gamma-irradiated mice treated with preserved HFL. 
between 4 to 20 days. They returned to the preirradiation level between 12 and 
30 days. 
   Erythrocyte count. The changes of erythrocyte count in the treated ones are 
shown in Fig. 21. The lowest level of the erythrocyte count occurred at 4 to 12 
days and then the count increased quickly or gradually and recovered to the 
level of preirradiation at 14 to 28 days. 
   Reticulocyte count. The changes of reticulocyte count in the treated ones 
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    Fig. 23. Platelet count in the gamma-irradiated mice treatedwith preserved HFL. 
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 Fig. 24. Hemoglobin content in the gamma-irradiated mice treated with preserved HFL. 
are shown in Fig. 22. The reticulocyte count in the treated ones decreased to 
nil by 2 to 5 days and then the count increased quickly or gradually to the level 
of preirradiation at 18 to 30 days. 
   Platelet count. The changes of platelet count are shown in Fig. 23. The 
count decreased to the level of 50 to 220 x103 at 5 to 12 days and then the count 
increased to the level of preirradiation at 15 to 25 days. 
   Hemoglobin content. The hemoglobin content are shown in Fig. 24. The 
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               Table 6. The times of appearance of early regeneration and complete recovery in the 
                 hematopoietic tissues in gamma-irradiated mice treated with preserved HFL.
            Preservation Bone marrowSpleenThymus Lymphnode 
           periodredpulp white pulp                         eg. cp. eg. cp. eg. cp. eg. cp. eg. cp. 
            Fresh4 14 7 21 — 70-90 10 70-90 — 70-90 
        30 days 4 14 4 21 — 75 14 7575 
150 days 6 15 9 21 — 115 9 115 — 115 
         270 days 4 14 7 20 — 70 20 70 — 70 
        360 days 5 20 8 21 — — 14 — — — 
              The number of nucleated cells injected was 20 million. They were suspended in 10% 
                DMSO-TC199 solution and preserved for 30 to 360 days at-80°C. 
               eg. means early regeneration in the tissues in the treated mice. 
               cp. means complete recovery in the tissues in the treated mice. 
              The numbers in the Table show the days after irradiation. 
         hemoglobin content decreased to the level of 70 to 95% Sahli at 9 to 18 days and 
          then increased to the level of preirradiation at 21 to 28 days. 
             Histological findings. The times of appearance of early regeneration and 
          complete recovery are shown in Table 6. The times of appearance of early 
          regeneration and complete recovery of the bone marrow and the red pulp of the 
          spleen were almost the same as those in the fresh HFL transplantation. How-
          ever, complete recovery of the lymphatic tissues later than that in IFL trans-
           plantation. 
                                   DISCUSSION 
             Mice exposed to a lethal dose of X radiation will survive the acute hema-
          topoietic death when they are given a postirradiation inoculation of bone marrow 
          or spleen. Treatment with isologous bone marrow produces excellent survivals, 
          while homologous marrow affords only a temporary recovery ; the mice succumb 
          during a secondary phase of the irradiation sydrome. As for the late death, 
          there have been two theories. Barnes and Loutit2 postulated an immunological 
          response of marrow graft against the irradiated host. Makinodan and his 
coworkers3'''5', however, postulated a delayed immunological response of the host 
          to the tissues of the foreign strain. There is an increasing body of evidences in 
          support of this former theory as the explantation of the secondary phase. If 
          there exists a graft versus host reaction when ,adult tissues is used, fetal hema-
          topoietic tissue might not initiate such a reaction owing to its immunological im-
          maturity (immunological nonreactivity). 
             The survival rates in the fresh homologous bone marrow transplantation 
         when the number of nucleated cells injected was 5 million were as follows : 41% 
         at 14 days, 18% at 21 days, 17% at 30 days, 10% at 60 days, 5% at 90 days after 
          irradiation. The survival rates in the fresh homologous bone marrow trans-
         plantation when the number of nucleated cells injected was 10 million were as 
follows : 77% at 14 days, 58% at 21 days, 56% at 30 days, 30% at 60 days, 20% at 
         90 days and 16% at 120 days. As compared with the homologous bone marrow 
( 52 )
            Preserved Hematopoietic Tissues for Treatment of Mice. (III) 
transplantation, better survivals from acute radiation injury by the transplanta-
tion of HFL were obtained. The delayed death, however, occurred also in HFL 
treatments, as characterized by body weight loss, emaciation, and skin lesion. 
 Uphoffs'10>, Lengerova34', and Barnes et al12'. indicated that fetal liver in different 
genetic combinations was capable of altering delayed death in foreign bone mar-
row transplantation. But Urso et al14'. did not find a good long term survival 
in the mice transplanted with homologous fetal liver. Trentin35' reported that 
fetal blood-forming tissues were not superior to adult bone marrow in promoting 
long term survival after irradiation. In the author's experiments, the best sur-
vival was obtained in the transplantation with 5 million HFL cells. In the ex-
periments, third trimester donors (15 to 19 days gestation) were used for the 
treatments. According to Tschetter et al.36,37), the gestational age of donor fetal 
liver appeared to have no influence on the early death and fetal liver in the 
second trimester (12 to 14 days gestation) could protect the lethally irradiated 
mice from the late death better than that in the third trimester. 
   To preserve HFL cells for a long term, 15% glycerol-Tyrode's solution or 10% 
DMSO-TC 199 solution was used. The fetal liver cell suspensions were slowly 
frozen and used after fast thawing. Generally speaking, the preserved HFL could 
protect well the lethally irradiated mice from acute radiation death. However, 
delayed death occurred between the 21st to 120th day after irradiation. Hema-
tologically, the speed of recovery to the preirradiation level was dependent on 
the number of nucleated cells injected and in some case, preservation period. 
The bone marrow and the red pulp of spleen did recover to preirradiation state 
as quickly as in the isologous fetal liver or bone marrow transplantation. Slow 
rate of recovery of the thymus, the white pulp of the spleen and the lymphatic 
tissue was recognized30>. They were filled with plasma cells and reticular cells 
on the 30th day. 
                           SUMMARY 
   1. The fresh homologous fetal liver cells supposed to be immunologically 
immature protected the lethally irradiated mice from acute radiation illness, but 
late death occurred. Treatment with 5 million HFL cells produced an excellent 
120 day-survival. 
   2. The HFL suspended in 15% glycerol-Tyrode's solution or 10% DMSO-TC 
199 solution and preserved for 30 to 360 days at —80°C protected the lethally 
irradiated mice from acute radiation illness, but delayed death occurred. The 360-
day preserved HFL could still protect the lethally irradiated mice. 
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                       Explantation of Plates 
         Plate 1. Fetal liver of  Naz strain mice of 19 days gestation. Immature 
         hematopoietic cells are seen.H-E stain x400 
         Plate 2. Bone marrow ; 4 days after 900r gamma-irradiation and treat-
          ment with 360-day preserved HFL suspended in 15% glycerol-
           Tyrode's solution. This is early regeneration. The number of nu-
           cleated cells injected was 20 million.H-E stain X400
         Plate 3. Bone marrow ; 14 days after 900r gamma-irradiation and treat-
           ment with fresh HFL. The number of nucleated cells injected was 5 
           million. The cellularity is normal,.H-E stain x100 
         Plate 4. Spleen ; 60 days after 900r gamma-irradiation and treatment 
           with 270-day preserved HFL suspended in 10°o DMSO-TC199 solu-
          tion. The white pulp is completely wasted. H-E stain x400 
         Plate 5. Thymus ; 75 days after 900r gamma-irradiation and treatment 
           with 360-day preserved HFL suspended in 15% glycerol-Tyrode's 
           solution. The number of nucleated cells injected was 20 million. A 
           marked increase in number of thymocytes in the thymus.
                                                       H-E stain x 100 
         Plate 6. Brachial lymphnode ; 60 days after 900r gamma-irradiation and 
           treatment with 270-day preserved HFL suspended in 10°o DMSO-
           TC199 solution and the number of nucleated cells injected was 20 
          million. The lymphnode is wasted.H-E stainx400
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